![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
Fuling Technology
001356
KLT
831689
Hand Enterprise Solutions
300170
4
GRANDTECH
835184
5
Doushen(Beijing) Education & Technology Inc.
300010
US Stock MarketDetailed Quotes
VIGL Vigil Neuroscience
- 2.350
- +0.320+15.76%
Close Jan 23 16:00 ET
- 2.290
- -0.060-2.55%
Post 17:59 ET
96.07MMarket Cap-1.14P/E (TTM)
2.940High2.040Low42.19MVolume2.290Open2.030Pre Close102.29MTurnover190.22%Turnover RatioLossP/E (Static)40.88MShares6.06052wk High1.08P/B52.12MFloat Cap1.49052wk Low--Dividend TTM22.18MShs Float18.270Historical High--Div YieldTTM44.34%Amplitude1.490Historical Low2.424Avg Price1Lot Size
Vigil Neuroscience Stock Forum
Sign in to post a comment
$Vigil Neuroscience (VIGL.US)$ 🤫🤫🤫 be quiet
2
$Vigil Neuroscience (VIGL.US)$ hope there some fun here
$Vigil Neuroscience (VIGL.US)$ ok.. its time..
$Vigil Neuroscience (VIGL.US)$ take your time.. i can wait
1
$Vigil Neuroscience (VIGL.US)$ why so slow? what is going on?
$Vigil Neuroscience (VIGL.US)$ About to hit 2.4 million live volume! 10X the average daily for last 90 days
1
1
$Vigil Neuroscience (VIGL.US)$ Reuters· 1 min ago
Vigil Neuroscience Inc - Vg-3927 Showed Favorable Safety and Tolerability Profile
Vigil Neuroscience Inc - Vg-3927 Showed Favorable Safety and Tolerability Profile
$Vigil Neuroscience (VIGL.US)$
Vigil Neuroscience Reports Positive Data from its Phase 1 Clinical Trial Evaluating VG-3927 for the Potential Treatment of Alzheimer's Disease
Thursday, 23rd January at 7:00 am
- Safety, tolerability, pharmacokinetic, and pharmacodynamic profile supports continued development of VG-3927 as potential once-daily oral therapy for Alzheimer's disease (AD) -
- Robust and dose-dependent reductions of sTREM2 were achieved demonstrating sustained functional target engag...
Vigil Neuroscience Reports Positive Data from its Phase 1 Clinical Trial Evaluating VG-3927 for the Potential Treatment of Alzheimer's Disease
Thursday, 23rd January at 7:00 am
- Safety, tolerability, pharmacokinetic, and pharmacodynamic profile supports continued development of VG-3927 as potential once-daily oral therapy for Alzheimer's disease (AD) -
- Robust and dose-dependent reductions of sTREM2 were achieved demonstrating sustained functional target engag...
2
$Vigil Neuroscience (VIGL.US)$ w is the actual TP in reality ? I don’t believe in any news all scam.
$Vigil Neuroscience (VIGL.US)$ Vigil Neuroscience | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Vida Ventures GP III, L.L.C.(12.7%),Stefan Vitorovic(12.7%), etc.
SEC· 21 mins ago
SEC· 21 mins ago
No comment yet
Trending Stocks
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Stocks & Industries to Watch Under Trump's Second Presidency
Key takeaways Tech stocks underwent substantial growth due to tax cuts and reduced corporate regulations in Trump's first term along with defense and aerospace
Discussing
December CPI comes in as expected, is that enough?
U.S. December CPI rose 2.9% year-on-year, aligning with expectations but marking a three-month inflation increase trend. The market reacted
In One Chart
Jan 15 22:05
Here's the Breakdown for December CPI, in One Chart
TopNavs : stop spamming
小竜 OP : how?